News

All News

Press Releases

Media

All Videos

Digital Detail

Independent Corner

Insights

Interviews

Medical World News

Microsites

Peer Exchange

Perfect Consult

Podcasts

Practice Pearls

Student Voices

Webinars/Webcasts

Conferences

Conference Coverage

Conference Listing

Publications

All Publications

Author Submission

Clinical

503B Compounding Pharmacy

ADHD

Allergy

Alzheimer Disease

Anxiety

Asthma

Atopic Dermatitis

Biosimilars

Bipolar Disorder

Brain Health

Breast Cancer

C. Difficile

COPD

COVID Treatment

Cardiovascular Health

Cervical Cancer

Cholangiocarcinoma

Chronic Kidney Disease

Chronic Lymphocytic Leukemia

Colorectal Cancer

Coronavirus

Cough and Cold

Depression

Dermatology

Diabetes

Digestive Health

Dry Eye Disease

Epilepsy

Eye Care

Future of Pharmacy

Gastrointestinal Cancer

Gastrointestinal Health

Gout

Heart Failure

Hematology

Hepatitis

IVIG

Immunization

Immuno-oncology

Infectious Disease

Lung Cancer

Lymphoma

Macular Degeneration

Mental Health

Migraine

Multiple Myeloma

Multiple Sclerosis

Neurology

Neutropenia

Osteoporosis

Ovarian Cancer

Pain Management

Parkinson Disease

Pediatrics

Pharmacy Heroes

Pharmacy Management

Pneumococcal

PrEP

Prostate Cancer

Psoriasis

Psoriatic Arthritis

Reimbursement

Respiratory Syncytial Virus

Rheumatoid Arthritis

Schizophrenia

Skin Cancer

Sleep

Veterinary Pharmacy

Vitamins and Supplements

Weight Management

Women's Health

Zoster

Events

Upcoming Events

Upcoming Webinars

CME/CE

Resources

Clinical Forum

Effective Treatment of Chronic Graft Versus Host Disease (cGVHD) Clinical Forums

Cou-Co

Educated Patient

Information for the Pharmacist

Interactive Tools

Partners

Whiteboards

Subscribe

Print Subscription

eNewsletter

Alana Hippensteele is a managing editor at 

®. She has a master's in Critical Theory and Creative Research from Pacific Northwest College of Art and a bachelor's degree in English and Art History. She has worked as an English instructor at Temple University and held editorial positions at 

Articles

This is the first trial to show that a MRD-guided approach with treatment beyond MRD negativity has a significant advantage over chemotherapy, both in terms of PFS and OS.

Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL

The study results shine a light on the potential need for further policy changes that promote gender equity and bridge the gap in R01 funding awarded to female applicants.

Gender Gap in NIH-Awarded Research Grants Persists in the Field of Non-Malignant Hematology

 She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.

Videos

Median overall survival is set to be more than 2 years, which is more than double the overall survival of current frontline therapies.

Golidocitinib Demonstrates Significant Survival Benefits For Patients with Peripheral T-cell Lymphoma

He also provides insight for students training in classical hematology, oncology hematology, or oncology pharmacy.

ASH President Speaks on Pharmacists, Novel Innovations in Hematology

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Jeremy Burtenshaw

Articles